Deaths from heart disease are surging globally [1]. And it's tragic because there are so many ways to cut the risk. One of the most powerful—and surprisingly affordable—approaches costs just $5.45 a month.
This post examines the big controversy surrounding cholesterol. Conflicting information online often suggests that low cholesterol is dangerous and high cholesterol is perfectly safe. The science on both sides is examined carefully here, drawing on large randomized trials and population analyses, so you can make an informed decision about what approach is right for you. Finally, the $5.45-a-month strategy—widely recommended by cardiologists when lifestyle changes alone aren't enough—is covered in detail, including common myths about side effects and how to get the most benefit at the lowest dose.
The Controversy about Cholesterol
Deaths from cardiovascular disease surged 60% globally over the last 30 years [1]. And behind many of these deaths is a major debate. Most cardiologists hold that if cholesterol—especially LDL cholesterol and ApoB—gets too high, it can slowly block the arteries around the heart and lead to a heart attack. But some voices online insist that high LDL is harmless and that lower cholesterol levels are actually more dangerous.

They often point to studies that appear to show people at the low end of LDL cholesterol have a higher risk of dying [2].

This raises the question: is there some conspiracy by doctors and pharmaceutical companies to push unnecessary medications? Before letting the conspiracy theories run wild, it's worth digging into what the science actually says.
1. U-Shaped Curves in Health
You'll often see what looks like a U-shaped pattern in many areas of health. A classic example is body mass index (BMI). A meta-analysis on BMI in older adults shows higher mortality risks at both very high and very low BMIs [3].

Another example is blood pressure: too high and too low can both look risky on the surface [4]. If you see a similar curve for cholesterol, does that mean low cholesterol is truly deadly—and that it's better to have high cholesterol?
Not exactly. The real explanation is subtler. People with extremely low cholesterol or extremely low BMI often fall into two categories: the elderly and those with chronic illnesses. In old age, more health problems naturally emerge. For BMI, as people get older and frailer, appetite decreases, weight is lost—and mortality risk goes up. That weight loss can show up as "low BMI" in the data, yet it's not that low BMI caused the higher mortality; it's that underlying health issues led to the low BMI. A similar phenomenon happens with cholesterol: severe chronic illness (such as cancer or liver disease) can drive cholesterol levels very low.
2. Adjusting for Confounders
When studies control for factors like advanced age and chronic disease, the "U-shape" often disappears. Consider a large cohort study of over 40,000 patients with coronary artery disease [5]. Initially, the data seemed to show a high mortality risk at the low end of non-HDL cholesterol.

But after adjusting for age, malnutrition, and other markers of poor health, that "low cholesterol" mortality spike vanished. Instead, higher levels of cholesterol were associated with higher mortality.

This pattern holds up across a broad array of research. One major review examined more than 200 studies, including randomized trials and analyses of over 2 million people, and found a consistent link between higher LDL-cholesterol and the rate of heart disease [6]. The authors concluded that LDL is not just correlated with heart disease, but that LDL itself is a causal factor in driving atherosclerosis.

3. What if You're Otherwise Healthy?
Some people argue that if a person is the perfect weight, has no signs of diabetes, and has ideal blood pressure, there's no need to worry about LDL cholesterol. However, an important study known as the PESA study found that atherosclerotic plaque can still develop in individuals who otherwise have ideal cardiovascular risk factors, if their LDL-c rises above around 50–60 mg/dL [7].

In other words, even when someone has done everything right—eating well and staying active—elevated LDL can quietly damage the arteries. The PESA findings reinforce the idea that ideal LDL targets are lower than traditional guidelines might suggest. Many cardiovascular experts recommend aiming below 50–60 mg/dL to minimize atherosclerosis progression.
4. Typical LDL Levels
In reality, most people have LDL levels higher than 50–60 mg/dL. A recent study shows that while LDL levels among U.S. adults have decreased over the past two decades, they still hover around an average of 112 mg/dL [8]. That is nearly double the more aggressive target mentioned above. For those in that higher range, there are steps that can help move toward optimal levels.
Lowering Cholesterol – Diet
So, how can cholesterol levels be brought down? The first lever to pull is diet. But to understand how current dietary guidelines evolved, it helps to look at the mistakes doctors and nutritionists have made along the way.

5. Early Mistakes: Low-Fat Everything
In the 1950s, physiologist Ancel Keys conducted a large study across seven countries. He noted that populations eating large amounts of saturated fats (e.g., in butter and fatty meats) had more heart problems, whereas those with lower saturated fat consumption had fewer heart issues. This led to the widespread recommendation to reduce total fat intake. By the 1970s and 1980s, "low-fat" was all the rage in the grocery aisles.
However, removing fats—especially in processed foods—often meant replacing them with sugar to maintain taste and texture. Consumers thought they were making a "healthy" choice by buying low-fat products, yet they were actually boosting their sugar intake. Studies have linked increased sugar consumption to higher risks of cardiovascular disease [9].
To complicate matters, in an effort to reduce butter consumption, people turned to margarine—at least the original versions. These were made using hydrogenation, which creates trans fats. Trans fats turned out to be a nutritional nightmare, significantly increasing heart disease risk. Modern forms of margarine generally no longer contain trans fats, but this historical misstep is worth remembering.

6. Saturated Fats vs. Unsaturated Fats
Another long-standing debate revolves around saturated vs. unsaturated fats. Saturated fats are typically found in high amounts in foods like fatty meats, full-fat dairy, coconut oil, and palm oil. Research has shown that saturated fats can elevate LDL cholesterol levels [10]. Meanwhile, substituting saturated fats with unsaturated sources (like extra-virgin olive oil, nuts, seeds, and avocados) leads to a notable reduction in heart disease risk—studies estimate around 17% [11].
Earlier public health campaigns lumped all fats together, demonizing even healthy unsaturated fats. But the evidence now shows that emphasizing unsaturated fats—particularly in the context of a Mediterranean-style diet—can be highly protective. The CORDIOPREV trial compared a low-fat diet to a Mediterranean diet rich in unsaturated fats and found about a 25% lower risk of heart attacks among those following the Mediterranean diet [12].

7. Cholesterol in Foods vs. Cholesterol in Blood
The final point of confusion is the relationship between the cholesterol we eat (dietary cholesterol) and the cholesterol in our blood. Although saturated fat clearly boosts LDL levels, dietary cholesterol from sources like eggs has a relatively small effect on blood cholesterol for most people [13]. For a long time, eggs were lumped in with other "high-cholesterol" foods, but the evidence now suggests that for otherwise healthy individuals, having eggs in moderation is usually fine.

8. When Diet Alone Isn't Enough
Diet, of course, is foundational. A high intake of saturated and trans fats makes it very difficult to maintain low LDL levels. At the same time, some people—despite following a Mediterranean-style diet and maintaining a healthy weight—find that their LDL stays well above the 50–60 mg/dL threshold because of genetic factors that drive higher cholesterol production in the liver. This is where medications can be a game-changer.
The $5.45 a Month Strategy
Many cardiologists advocate for the use of low-dose statin medications when lifestyle measures alone aren't sufficient to bring LDL levels down. Generic statins can be remarkably inexpensive—rosuvastatin is available for about $5.45 a month at certain pharmacies, making it a cost-effective approach to reducing heart attack risk.
Yet online, dire warnings claim that statins cause dementia. This concern has been repeatedly studied, and the overwhelming conclusion is that statins do not impair cognition [14]. In fact, updated clinical guidelines and multiple analyses now suggest that, for people with high cholesterol, statins may even reduce the risk of dementia [15].
Some worry that statins might reduce testosterone or cause muscle pains. Large-scale data show that typical statin dosages don't significantly affect testosterone levels [16]. Meanwhile, genuine statin-induced muscle pain appears in about 1 to 2 out of 100 patients [18][16]. Even among those few affected, most cases are mild. The risk is lower still with low-dose statins, especially hydrophilic ones like rosuvastatin or pravastatin, which tend not to penetrate muscle tissue as readily as hydrophobic types.

9. High-Dose vs. Low-Dose Statins
When examining how statins work, about 80% of their LDL-lowering benefits come from relatively modest doses. There's often no need to maximize the dose when a low or moderate amount produces a good response. If high-dose statins cause muscle aches, or there are concerns about potential side effects, discussing a switch to a low dose of a hydrophilic statin with a physician is a reasonable step. Rosuvastatin at 5 mg daily is one widely used option in this category.
10. How Much Do Statins Help?
One Cochrane review of statins for "primary prevention"—meaning in people who haven't yet had a cardiovascular event—found that if 1,000 people take a statin for five years, about 18 of them would avoid a major cardiovascular event, such as a heart attack [19]. It's a real benefit, and importantly, the protective effect grows the longer the medication is taken. When thinking about heart disease prevention, it's wise to consider lifetime risk, not just five-year risk.
11. Adding Ezetimibe
Sometimes even low-dose statins aren't enough to reach the target LDL. That's where ezetimibe can help. Ezetimibe signals the gut to absorb less cholesterol. The body uses bile (rich in cholesterol) to digest fat in the intestines, and blocking the reabsorption of that cholesterol lowers the amount circulating in the bloodstream.
Ezetimibe is generally well-tolerated—some individuals experience mild gastrointestinal upset, but that usually subsides over time. More importantly, combining ezetimibe with a low- or moderate-dose statin is often more effective, with fewer side effects, than simply pushing a statin to the highest dose [20][21]. Recent meta-analyses show that combination therapy can achieve lower LDL levels and a reduced risk of certain side effects compared to high-intensity statin treatment alone.
Conclusion
Diet and medications are both powerful tools for reducing heart disease risk, but they aren't the entire story. Atherosclerotic plaques accumulate in the arteries over time, and recent groundbreaking studies suggest it may be possible to reverse some of this buildup through specific types of exercise. For those who want to learn which forms of physical activity may help clear plaque from the arteries, the next post dives deeper into this exciting research.
References
2. https://www.nature.com/articles/s41598-021-01738-w
3. https://www.sciencedirect.com/science/article/pii/S0002916523050244#f2
4. https://www.sciencedirect.com/science/article/pii/S0735109714029088
5. https://www.sciencedirect.com/science/article/pii/S0261561422000371
6. https://pubmed.ncbi.nlm.nih.gov/28444290/
7. https://www.sciencedirect.com/science/article/pii/S0735109721051159?via%3Dihub
8. https://pmc.ncbi.nlm.nih.gov/articles/PMC9973640
9. https://pmc.ncbi.nlm.nih.gov/articles/PMC4856550/
10. https://pmc.ncbi.nlm.nih.gov/articles/PMC2943062
12. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)00122-2/abstract
13. https://pmc.ncbi.nlm.nih.gov/articles/PMC10495817/
14. https://pubmed.ncbi.nlm.nih.gov/25575908/
15. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01296-0/fulltext
17. https://youtu.be/bpBrRuIXUVI
18. https://www.thelancet.com/article/S0140-6736(22)01545-8/fulltext
19. https://www.cochrane.org/CD004816/VASC_statins-primary-prevention-cardiovascular-disease
20. https://jamanetwork.com/journals/jamacardiology/fullarticle/2826516



